Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
Las enfermedades alérgicas suponen un coste directo de entre 1.800 y 6.600 euros por paciente al año VALENCIA, España, June 02, 2024 (GLOBE NEWSWIRE) -- Las enfermedades alérgicas suponen un coste de entre 1.823 y 6.656 euros por paciente al año si solo tenemos en cuenta los gastos directos...
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
EAACI Congress Kicks Off in Valencia, Spain
Arranca en Valencia el Congreso de la EAACI VALENCIA, España, May 31, 2024 (GLOBE NEWSWIRE) -- Con el lema “Revolucionando la atención al paciente a través del poder de la ciencia de los datos”, ha comenzado el congreso internacional...
EAACI Congress Kicks Off in Valencia, Spain
EAACI Congress Kicks Off in Valencia, Spain EAACI Congress Kicks Off in Valencia, Spain Precision Medicine, Immunotherapy, and Artificial Intelligence (AI) as Key Topics
22157.jpg
Allergy Vaccine Market Trends, Forecast and Competitive Analysis: A $3.6 Billion Market by 2030 with a CAGR of 7.5% from 2024 to 2030
May 31, 2024 04:18 ET | Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Allergy Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The global...
EAACI Congress 2024
Presentación del Congreso de la Academia Europea de Alergología e Inmunología Clínica (EAACI) que se celebrará en Valencia del 31 de mayo al 3 de junio VALENCIA, España, May 30, 2024 (GLOBE NEWSWIRE) -- Con el lema «Revolucionando la atención al paciente a través del poder de la ciencia de los datos», el congreso destacará el papel...
EAACI Congress 2024
Presentation of the Congress of the European Academy of Allergy and Clinical Immunology (EAACI) to be held in Valencia from May 31 to June 3 We are delighted to invite you to the opening press conference of our EAACI Annual Congress 2024 in Valencia or online via the link below.
download.png
Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal
May 23, 2024 08:47 ET | Altamira Therapeutics Ltd
Hamilton, Bermuda, May 23, 2024 (GLOBE NEWSWIRE) -- HAMILTON, BERMUDA – May 23, 2024 -- Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and...
Atopia Therapeutics, Formerly HpVac, Announces Appointment of Dr. Gregoire Chevalier as CEO and Business Update
May 07, 2024 04:09 ET | AKAMPION
Geneva (Switzerland), May 7, 2024 – Atopia Therapeutics, a leader in the development of breakthrough asthma and allergy therapies, today announced the appointment of Dr. Grégoire Chevalier as Chief...
EAACI Congress 2024
Congrès EAACI 2024 : innovations et progrès dans le traitement des allergies
April 30, 2024 02:58 ET | European Academy of Allergy and Clinical Immunology
Lors de ce congrès, plus de 150 sessions scientifiques seront présentées. Les sujets abordés se concentreront sur les progrès de la science environnementale, les allergies alimentaires, les...